(MZTI) The Marzetti - Overview

Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 3.838m USD | Total Return: -17.2% in 12m

Stock Dips, Dressings, Breads, Sauces, Toppings
Total Rating 44
Safety 88
Buy Signal -0.40
Market Cap: 3,838m
Avg Trading Vol: 38.8M USD
ATR: 3.38%
Peers RS (IBD): 29.3
Risk 5d forecast
Volatility26.8%
Rel. Tail Risk-8.77%
Reward TTM
Sharpe Ratio-0.70
Alpha-28.00
Character TTM
Beta0.335
Beta Downside0.367
Drawdowns 3y
Max DD33.31%
CAGR/Max DD-0.32
EPS (Earnings per Share) EPS (Earnings per Share) of MZTI over the last years for every Quarter: "2021-03": 1.35, "2021-06": 1.43, "2021-09": 1.24, "2021-12": 1.48, "2022-03": 0.71, "2022-06": 1.66, "2022-09": 1.36, "2022-12": 1.45, "2023-03": 0.89, "2023-06": 1.19, "2023-09": 1.59, "2023-12": 1.87, "2024-03": 1.03, "2024-06": 1.34, "2024-09": 1.62, "2024-12": 1.78, "2025-03": 1.49, "2025-06": 1.18, "2025-09": 1.71, "2025-12": 2.1506, "2026-03": 0,
EPS CAGR: -48.78%
EPS Trend: -18.5%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of MZTI over the last years for every Quarter: 2021-03: 357.249, 2021-06: 385.566, 2021-09: 392.056, 2021-12: 428.427, 2022-03: 403.494, 2022-06: 452.413, 2022-09: 425.537, 2022-12: 477.394, 2023-03: 464.935, 2023-06: 454.661, 2023-09: 461.572, 2023-12: 485.916, 2024-03: 471.446, 2024-06: 452.825, 2024-09: 466.558, 2024-12: 509.301, 2025-03: 457.836, 2025-06: 475.427, 2025-09: 493.472, 2025-12: 517.953, 2026-03: null,
Rev. CAGR: 6.89%
Rev. Trend: 72.7%
Qual. Beats: 0
Description: MZTI The Marzetti

The Marzetti Company (MZTI) manufactures and markets specialty food products. The company operates in two segments: Retail and Foodservice. This dual-segment approach is common in the food industry, allowing companies to reach both individual consumers and commercial clients.

MZTIs product portfolio includes frozen garlic breads (New York Bakery), frozen rolls (Sister Schuberts), various salad dressings (Marzetti, Cardinis), dips, croutons, and frozen pasta. The company also produces licensed products for other brands such as Olive Garden and Chick-fil-A. This strategy of brand licensing provides additional revenue streams and leverages established brand recognition.

Products are distributed through sales personnel, food brokers, and distributors to retailers and restaurants. The company, founded in 1896, changed its name from Lancaster Colony Corporation to The Marzetti Company in June 2025. Further research on platforms like ValueRay can provide deeper insights into MZTIs financial performance and market position.

Headlines to Watch Out For
  • Retail segment sales drive revenue growth
  • Foodservice demand impacts profitability
  • Ingredient cost fluctuations affect margins
  • Brand licensing agreements boost revenue
  • Private label competition pressures pricing
Piotroski VR‑10 (Strict) 8.0
Net Income: 179.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.21 > 0.02 and ΔFCF/TA 6.17 > 1.0
NWC/Revenue: 15.98% < 20% (prev 16.51%; Δ -0.53% < -1%)
CFO/TA 0.22 > 3% & CFO 292.1m > Net Income 179.9m
Net Debt (-124.0m) to EBITDA (298.0m): -0.42 < 3
Current Ratio: 2.72 > 1.5 & < 3
Outstanding Shares: last quarter (27.4m) vs 12m ago -0.29% < -2%
Gross Margin: 24.07% > 18% (prev 0.23%; Δ 2.38k% > 0.5%)
Asset Turnover: 151.4% > 50% (prev 153.3%; Δ -1.84% > 0%)
Interest Coverage Ratio: 149.2 > 6 (EBITDA TTM 298.0m / Interest Expense TTM 1.55m)
Altman Z'' 10.00
A: 0.23 (Total Current Assets 491.4m - Total Current Liabilities 180.7m) / Total Assets 1.33b
B: 1.26 (Retained Earnings 1.68b / Total Assets 1.33b)
C: 0.18 (EBIT TTM 231.0m / Avg Total Assets 1.28b)
D: 6.24 (Book Value of Equity 1.85b / Total Liabilities 296.0m)
Altman-Z'' Score: 13.41 = AAA
Beneish M -2.98
DSRI: 1.02 (Receivables 103.8m/99.2m, Revenue 1.94b/1.90b)
GMI: 0.97 (GM 24.07% / 23.46%)
AQI: 1.21 (AQ_t 0.22 / AQ_t-1 0.18)
SGI: 1.02 (Revenue 1.94b / 1.90b)
TATA: -0.08 (NI 179.9m - CFO 292.1m) / TA 1.33b)
Beneish M-Score: -2.98 (Cap -4..+1) = A
What is the price of MZTI shares? As of April 05, 2026, the stock is trading at USD 138.33 with a total of 231,924 shares traded.
Over the past week, the price has changed by +3.29%, over one month by -14.32%, over three months by -12.16% and over the past year by -17.21%.
Is MZTI a buy, sell or hold? The Marzetti has no consensus analysts rating.
What are the forecasts/targets for the MZTI price?
Wallstreet Target Price 192 38.8%
Analysts Target Price - -
MZTI Fundamental Data Overview as of 01 April 2026
P/E Trailing = 21.3859
P/E Forward = 36.1011
P/S = 1.9738
P/B = 3.8229
P/EG = 3.1204
Revenue TTM = 1.94b USD
EBIT TTM = 231.0m USD
EBITDA TTM = 298.0m USD
Long Term Debt = 38.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.7m USD (from shortTermDebt, last fiscal year)
Debt = 77.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -124.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.71b USD (3.84b + Debt 77.5m - CCE 201.6m)
Interest Coverage Ratio = 149.2 (Ebit TTM 231.0m / Interest Expense TTM 1.55m)
EV/FCF = 13.60x (Enterprise Value 3.71b / FCF TTM 273.2m)
FCF Yield = 7.35% (FCF TTM 273.2m / Enterprise Value 3.71b)
FCF Margin = 14.05% (FCF TTM 273.2m / Revenue TTM 1.94b)
Net Margin = 9.25% (Net Income TTM 179.9m / Revenue TTM 1.94b)
Gross Margin = 24.07% ((Revenue TTM 1.94b - Cost of Revenue TTM 1.48b) / Revenue TTM)
Gross Margin QoQ = 26.50% (prev 24.08%)
Tobins Q-Ratio = 2.80 (Enterprise Value 3.71b / Total Assets 1.33b)
Interest Expense / Debt = 0.17% (Interest Expense 132k / Debt 77.5m)
Taxrate = 22.61% (17.3m / 76.3m)
NOPAT = 178.8m (EBIT 231.0m * (1 - 22.61%))
Current Ratio = 2.72 (Total Current Assets 491.4m / Total Current Liabilities 180.7m)
Debt / Equity = 0.08 (Debt 77.5m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = -0.42 (Net Debt -124.0m / EBITDA 298.0m)
Debt / FCF = -0.45 (Net Debt -124.0m / FCF TTM 273.2m)
Total Stockholder Equity = 1.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.01% (Net Income 179.9m / Total Assets 1.33b)
RoE = 17.97% (Net Income TTM 179.9m / Total Stockholder Equity 1.00b)
RoCE = 22.21% (EBIT 231.0m / Capital Employed (Equity 1.00b + L.T.Debt 38.8m))
RoIC = 17.72% (NOPAT 178.8m / Invested Capital 1.01b)
WACC = 7.02% (E(3.84b)/V(3.92b) * Re(7.16%) + D(77.5m)/V(3.92b) * Rd(0.17%) * (1-Tc(0.23)))
Discount Rate = 7.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF] Terminal Value 84.86% ; FCFF base≈235.3m ; Y1≈290.3m ; Y5≈495.2m
[DCF] Fair Price = 392.8 (EV 10.65b - Net Debt -124.0m = Equity 10.77b / Shares 27.4m; r=7.02% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -18.54 | EPS CAGR: -48.78% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.67 | Revenue CAGR: 6.89% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=7.01 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=-1 | Growth EPS=+4.3% | Growth Revenue=+1.3%
EPS next Year (2027-06-30): EPS=7.36 | Chg7d=+0.000 | Chg30d=-0.026 | Revisions Net=-1 | Growth EPS=+5.0% | Growth Revenue=+2.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.2% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = -1.0% (Analyst 2.2% - Implied 3.2%)
External Resources